bd半岛体育·(中国)官方网站

Approved Laos Emergency Use Authorization (EUA)；

Stemirna received the clinical approval for phase I of the Chinese iteration vaccine on April 29th

Clinical approval was granted on January 4;

Phase I clinical trial was officially launched on March 25; 

Clinical approval for the variant of COVID-19 vaccine will be granted soon;

Emergency Project of the Ministry of Science and Technology "mRNA COVID-19 Vaccine" ;

State Council Vaccine Task Force Lead Unit;

Complete the IND application of COVID-19 mRNA vaccine

National Key Special Project of the Ministry of Science and Technology: Design and Construction of Fully Synthetic mRNA Therapeutic Vaccines for Malignant Tumors and Translational Research

Built the first mRNA GMP workshop in China；

the first mRNA tumor vaccine patient dosing (Beijing Cancer Hospital, Shanghai Changhai Hospital, etc.)

Stemirna has exclusive global rights to the LPP nano-delivery system for the development of MERS, influenza, and tuberculosis mRNA vaccines.

Dr. Hangwen Li returns to China to found Asia's first company focused on mRNA drug research and development